博舒替尼在CML治疗范例中占有一席之地

{"title":"博舒替尼在CML治疗范例中占有一席之地","authors":"M. Deininger","doi":"10.12788/J.CMONC.0002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":72649,"journal":{"name":"Community oncology","volume":"10 1","pages":"103-104"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bosutinib finds its place in the CML treatment paradigm\",\"authors\":\"M. Deininger\",\"doi\":\"10.12788/J.CMONC.0002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":72649,\"journal\":{\"name\":\"Community oncology\",\"volume\":\"10 1\",\"pages\":\"103-104\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Community oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12788/J.CMONC.0002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Community oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12788/J.CMONC.0002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}